Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05142436 · ClinicalTrials.gov registry record · NA
BAT3221032: A Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects
A NA study, sponsored by British American Tobacco (Investments) Limited.
- Completed
- Registry status
- NA
- Development phase
- 806
- Enrollment target
NCT05142436 is a NA study that has completed, run by British American Tobacco (Investments) Limited. The registered enrollment target is 806 participants.
The verdict
NCT05142436, a NA study, has completed, sponsored by British American Tobacco (Investments) Limited.
- COMPLETED
- Registry status
- NA
- Development phase
- 806 participants
- Enrollment target
Study Summary
This is a randomized, controlled, multi-center, open-label, 8-cohort parallel group study to assess changes in select biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH) in generally healthy smokers switching to the study investigational products (IPs), compared to subjects who continue to smoke, undergo smoking abstinence, or have never smoked.
Interventions
- OTHER Product A: Non-Combusted Cigarette Variant 42001402 and product use Mode B
- OTHER Product B: Non-Combusted Cigarette Variant 42001399 and product use Mode B
- OTHER Product C: Non-Combusted Cigarette Variant 42001401 and product use Mode B
- OTHER Product D: Non-Combusted Cigarette Variant 40007386 and product use Mode B
- OTHER Product E: Non-Combusted Cigarette Variant 42001402 and product use Mode A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 806 participants |
| Start Date | 2022-01-13 |
| Est. Completion | 2022-12-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05142436
The ClinicalTrials.gov registry entry for NCT05142436 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 806 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is British American Tobacco (Investments) Limited, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Product A: Non-Combusted Cigarette Variant 42001402 and product use Mode B is the first listed.
NCT05142436 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05142436 about?
NCT05142436 is a clinical study titled "BAT3221032: A Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects". This is a randomized, controlled, multi-center, open-label, 8-cohort parallel group study to assess changes in select biomarkers of exposure (BoE) and biomarkers of potential harm (BoPH) in generally healthy smokers switching to the study investigational products (IPs), compared to subjects who cont...
What is the current status of trial NCT05142436?
This trial is currently completed. It is a NA study. The enrollment target is 806 participants. The study started on 2022-01-13. Estimated completion is 2022-12-13.
What interventions are being tested in trial NCT05142436?
The interventions under investigation include: Product A: Non-Combusted Cigarette Variant 42001402 and product use Mode B (OTHER), Product B: Non-Combusted Cigarette Variant 42001399 and product use Mode B (OTHER), Product C: Non-Combusted Cigarette Variant 42001401 and product use Mode B (OTHER), Product D: Non-Combusted Cigarette Variant 40007386 and product use Mode B (OTHER), Product E: Non-Combusted Cigarette Variant 42001402 and product use Mode A (OTHER).
Who is sponsoring clinical trial NCT05142436?
This trial is sponsored by British American Tobacco (Investments) Limited, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.